Amerdari, Madalina .
HRN: 16-87-28 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/07/2022
CO-AMOXICLAV 625MG (TAB)
09/07/2022
09/14/2022
PO
1 Tab
Q12H
S/p NSVD
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes